Effect of Folic Acid in Reducing Negative Symptoms of Male Schizophrenia Patients
Phase 3
Recruiting
- Conditions
- Schizophrenia.Schizophrenia
- Registration Number
- IRCT20101130005280N55
- Lead Sponsor
- Gorgan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 30
Inclusion Criteria
Schizophrenia Diagnosis Based on V-DSM Diagnostic Criteria
Absence of Extrapyramidal Symptoms
Male Gender
Age Between 18 to 50 Years Old
Completing Informed Consent to Participate in the Study
Exclusion Criteria
Clinically Prominent Neurological or Organic Disease
Presence of Another Major I-Axis Diagnosis Based on V-DSM
Abnormality in Previous Tests
IQ Less than 70 Based on Standardized Tests
History of Drug Use (Excluding Nicotine and Caffeine)
ECT in the Past Two Weeks
Oral Antipsychotics in the Past Week or Long-Acting Antipsychotics in the Past Month
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reducing Negative Symptoms. Timepoint: Before the intervention and after 6 weeks of drug use. Method of measurement: With PANSS test questionnaire, the process of improvement and reduction of symptoms is measured.
- Secondary Outcome Measures
Name Time Method